nodes	percent_of_prediction	percent_of_DWPC	metapath
Linagliptin—ABCB1—Naltrexone—alcohol dependence	0.293	0.382	CbGbCtD
Linagliptin—ABCB1—Citalopram—alcohol dependence	0.194	0.253	CbGbCtD
Linagliptin—CYP3A4—Disulfiram—alcohol dependence	0.163	0.213	CbGbCtD
Linagliptin—CYP3A4—Citalopram—alcohol dependence	0.116	0.152	CbGbCtD
Linagliptin—Bronchial hyperreactivity—Naltrexone—alcohol dependence	0.02	0.102	CcSEcCtD
Linagliptin—Pancreatitis acute—Naltrexone—alcohol dependence	0.0113	0.0578	CcSEcCtD
Linagliptin—Diabetes mellitus—Acamprosate—alcohol dependence	0.00461	0.0236	CcSEcCtD
Linagliptin—Hyperlipidaemia—Citalopram—alcohol dependence	0.00459	0.0235	CcSEcCtD
Linagliptin—Pain in extremity—Naltrexone—alcohol dependence	0.00379	0.0194	CcSEcCtD
Linagliptin—Pancreatitis—Acamprosate—alcohol dependence	0.0034	0.0174	CcSEcCtD
Linagliptin—Nasopharyngitis—Naltrexone—alcohol dependence	0.00339	0.0173	CcSEcCtD
Linagliptin—Weight increased—Acamprosate—alcohol dependence	0.00315	0.0161	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.00305	0.0156	CcSEcCtD
Linagliptin—Urinary tract infection—Acamprosate—alcohol dependence	0.003	0.0153	CcSEcCtD
Linagliptin—Weight increased—Naltrexone—alcohol dependence	0.00298	0.0152	CcSEcCtD
Linagliptin—Infestation NOS—Naltrexone—alcohol dependence	0.00292	0.0149	CcSEcCtD
Linagliptin—Infestation—Naltrexone—alcohol dependence	0.00292	0.0149	CcSEcCtD
Linagliptin—Urinary tract infection—Naltrexone—alcohol dependence	0.00284	0.0145	CcSEcCtD
Linagliptin—Diabetes mellitus—Citalopram—alcohol dependence	0.00276	0.0141	CcSEcCtD
Linagliptin—Rash—Disulfiram—alcohol dependence	0.00252	0.0129	CcSEcCtD
Linagliptin—Headache—Disulfiram—alcohol dependence	0.00251	0.0128	CcSEcCtD
Linagliptin—Immune system disorder—Acamprosate—alcohol dependence	0.00251	0.0128	CcSEcCtD
Linagliptin—Hypoglycaemia—Citalopram—alcohol dependence	0.00246	0.0126	CcSEcCtD
Linagliptin—ABCB1—Abacavir transport and metabolism—ADH1A—alcohol dependence	0.00246	0.132	CbGpPWpGaD
Linagliptin—Malnutrition—Acamprosate—alcohol dependence	0.00241	0.0123	CcSEcCtD
Linagliptin—Pain in extremity—Citalopram—alcohol dependence	0.0024	0.0123	CcSEcCtD
Linagliptin—Immune system disorder—Naltrexone—alcohol dependence	0.00237	0.0121	CcSEcCtD
Linagliptin—Mediastinal disorder—Naltrexone—alcohol dependence	0.00237	0.0121	CcSEcCtD
Linagliptin—Back pain—Acamprosate—alcohol dependence	0.00234	0.0119	CcSEcCtD
Linagliptin—Malnutrition—Naltrexone—alcohol dependence	0.00228	0.0117	CcSEcCtD
Linagliptin—Back pain—Naltrexone—alcohol dependence	0.00221	0.0113	CcSEcCtD
Linagliptin—Angioedema—Acamprosate—alcohol dependence	0.00221	0.0113	CcSEcCtD
Linagliptin—Nasopharyngitis—Citalopram—alcohol dependence	0.00215	0.011	CcSEcCtD
Linagliptin—Cough—Acamprosate—alcohol dependence	0.00211	0.0108	CcSEcCtD
Linagliptin—Angioedema—Naltrexone—alcohol dependence	0.00209	0.0107	CcSEcCtD
Linagliptin—Arthralgia—Acamprosate—alcohol dependence	0.00206	0.0105	CcSEcCtD
Linagliptin—Myalgia—Acamprosate—alcohol dependence	0.00206	0.0105	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00204	0.0104	CcSEcCtD
Linagliptin—Pancreatitis—Citalopram—alcohol dependence	0.00204	0.0104	CcSEcCtD
Linagliptin—Cough—Naltrexone—alcohol dependence	0.00199	0.0102	CcSEcCtD
Linagliptin—Anaphylactic shock—Acamprosate—alcohol dependence	0.00197	0.0101	CcSEcCtD
Linagliptin—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.00196	0.105	CbGpPWpGaD
Linagliptin—Infection—Acamprosate—alcohol dependence	0.00196	0.01	CcSEcCtD
Linagliptin—Arthralgia—Naltrexone—alcohol dependence	0.00195	0.00994	CcSEcCtD
Linagliptin—Myalgia—Naltrexone—alcohol dependence	0.00195	0.00994	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00193	0.00987	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Citalopram—alcohol dependence	0.00193	0.00986	CcSEcCtD
Linagliptin—Skin disorder—Acamprosate—alcohol dependence	0.00191	0.00978	CcSEcCtD
Linagliptin—Weight increased—Citalopram—alcohol dependence	0.00189	0.00966	CcSEcCtD
Linagliptin—Anaphylactic shock—Naltrexone—alcohol dependence	0.00186	0.00953	CcSEcCtD
Linagliptin—Infection—Naltrexone—alcohol dependence	0.00185	0.00946	CcSEcCtD
Linagliptin—Infestation—Citalopram—alcohol dependence	0.00185	0.00946	CcSEcCtD
Linagliptin—Infestation NOS—Citalopram—alcohol dependence	0.00185	0.00946	CcSEcCtD
Linagliptin—Skin disorder—Naltrexone—alcohol dependence	0.00181	0.00925	CcSEcCtD
Linagliptin—Urinary tract infection—Citalopram—alcohol dependence	0.0018	0.0092	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.0018	0.00917	CcSEcCtD
Linagliptin—DPP4—cardiovascular system—alcohol dependence	0.00171	0.0877	CbGeAlD
Linagliptin—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.0017	0.00869	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.0017	0.00868	CcSEcCtD
Linagliptin—Constipation—Acamprosate—alcohol dependence	0.00169	0.00861	CcSEcCtD
Linagliptin—DPP4—pancreas—alcohol dependence	0.00167	0.0852	CbGeAlD
Linagliptin—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00161	0.00822	CcSEcCtD
Linagliptin—Constipation—Naltrexone—alcohol dependence	0.00159	0.00815	CcSEcCtD
Linagliptin—Urticaria—Acamprosate—alcohol dependence	0.00157	0.008	CcSEcCtD
Linagliptin—Immune system disorder—Citalopram—alcohol dependence	0.0015	0.00767	CcSEcCtD
Linagliptin—Mediastinal disorder—Citalopram—alcohol dependence	0.0015	0.00766	CcSEcCtD
Linagliptin—Urticaria—Naltrexone—alcohol dependence	0.00148	0.00757	CcSEcCtD
Linagliptin—Hypersensitivity—Acamprosate—alcohol dependence	0.00145	0.00742	CcSEcCtD
Linagliptin—Malnutrition—Citalopram—alcohol dependence	0.00145	0.0074	CcSEcCtD
Linagliptin—DPP4—digestive system—alcohol dependence	0.00142	0.0728	CbGeAlD
Linagliptin—Back pain—Citalopram—alcohol dependence	0.0014	0.00715	CcSEcCtD
Linagliptin—Hypersensitivity—Naltrexone—alcohol dependence	0.00137	0.00702	CcSEcCtD
Linagliptin—DPP4—blood—alcohol dependence	0.00136	0.0693	CbGeAlD
Linagliptin—Diarrhoea—Acamprosate—alcohol dependence	0.00135	0.00689	CcSEcCtD
Linagliptin—Angioedema—Citalopram—alcohol dependence	0.00132	0.00676	CcSEcCtD
Linagliptin—Diarrhoea—Naltrexone—alcohol dependence	0.00128	0.00652	CcSEcCtD
Linagliptin—Cough—Citalopram—alcohol dependence	0.00126	0.00645	CcSEcCtD
Linagliptin—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00125	0.0673	CbGpPWpGaD
Linagliptin—Rash—Acamprosate—alcohol dependence	0.00124	0.00635	CcSEcCtD
Linagliptin—Dermatitis—Acamprosate—alcohol dependence	0.00124	0.00634	CcSEcCtD
Linagliptin—Headache—Acamprosate—alcohol dependence	0.00123	0.00631	CcSEcCtD
Linagliptin—Arthralgia—Citalopram—alcohol dependence	0.00123	0.0063	CcSEcCtD
Linagliptin—Myalgia—Citalopram—alcohol dependence	0.00123	0.0063	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.00122	0.00625	CcSEcCtD
Linagliptin—Anaphylactic shock—Citalopram—alcohol dependence	0.00118	0.00604	CcSEcCtD
Linagliptin—DPP4—endocrine gland—alcohol dependence	0.00118	0.0601	CbGeAlD
Linagliptin—Rash—Naltrexone—alcohol dependence	0.00118	0.00601	CcSEcCtD
Linagliptin—Dermatitis—Naltrexone—alcohol dependence	0.00117	0.006	CcSEcCtD
Linagliptin—Infection—Citalopram—alcohol dependence	0.00117	0.006	CcSEcCtD
Linagliptin—Headache—Naltrexone—alcohol dependence	0.00117	0.00597	CcSEcCtD
Linagliptin—Skin disorder—Citalopram—alcohol dependence	0.00115	0.00586	CcSEcCtD
Linagliptin—DPP4—testis—alcohol dependence	0.00112	0.0573	CbGeAlD
Linagliptin—DPP4—nervous system—alcohol dependence	0.0011	0.0563	CbGeAlD
Linagliptin—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.00108	0.0055	CcSEcCtD
Linagliptin—DPP4—liver—alcohol dependence	0.00106	0.0542	CbGeAlD
Linagliptin—DPP4—central nervous system—alcohol dependence	0.00106	0.0542	CbGeAlD
Linagliptin—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00104	0.0558	CbGpPWpGaD
Linagliptin—Gastrointestinal disorder—Citalopram—alcohol dependence	0.00102	0.00521	CcSEcCtD
Linagliptin—Constipation—Citalopram—alcohol dependence	0.00101	0.00516	CcSEcCtD
Linagliptin—Urticaria—Citalopram—alcohol dependence	0.000939	0.0048	CcSEcCtD
Linagliptin—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.000884	0.0474	CbGpPWpGaD
Linagliptin—Hypersensitivity—Citalopram—alcohol dependence	0.000871	0.00445	CcSEcCtD
Linagliptin—DPP4—brain—alcohol dependence	0.000841	0.043	CbGeAlD
Linagliptin—Diarrhoea—Citalopram—alcohol dependence	0.000808	0.00413	CcSEcCtD
Linagliptin—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.000752	0.0403	CbGpPWpGaD
Linagliptin—Rash—Citalopram—alcohol dependence	0.000745	0.00381	CcSEcCtD
Linagliptin—Dermatitis—Citalopram—alcohol dependence	0.000744	0.0038	CcSEcCtD
Linagliptin—Headache—Citalopram—alcohol dependence	0.00074	0.00378	CcSEcCtD
Linagliptin—ABCB1—Allograft Rejection—PECR—alcohol dependence	0.000696	0.0374	CbGpPWpGaD
Linagliptin—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.000661	0.0355	CbGpPWpGaD
Linagliptin—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.000659	0.0354	CbGpPWpGaD
Linagliptin—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.000628	0.0337	CbGpPWpGaD
Linagliptin—DPP4—Peptide hormone metabolism—POMC—alcohol dependence	0.00051	0.0273	CbGpPWpGaD
Linagliptin—ABCB1—forebrain—alcohol dependence	0.000468	0.0239	CbGeAlD
Linagliptin—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.000464	0.0249	CbGpPWpGaD
Linagliptin—CYP3A4—digestive system—alcohol dependence	0.000464	0.0237	CbGeAlD
Linagliptin—CYP3A4—blood—alcohol dependence	0.000442	0.0226	CbGeAlD
Linagliptin—ABCB1—adrenal cortex—alcohol dependence	0.000434	0.0222	CbGeAlD
Linagliptin—ABCB1—cardiovascular system—alcohol dependence	0.000396	0.0202	CbGeAlD
Linagliptin—ABCB1—pancreas—alcohol dependence	0.000385	0.0197	CbGeAlD
Linagliptin—CYP3A4—endocrine gland—alcohol dependence	0.000383	0.0196	CbGeAlD
Linagliptin—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000371	0.0199	CbGpPWpGaD
Linagliptin—ABCB1—gonad—alcohol dependence	0.000359	0.0184	CbGeAlD
Linagliptin—CYP3A4—nervous system—alcohol dependence	0.000359	0.0184	CbGeAlD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000353	0.019	CbGpPWpGaD
Linagliptin—CYP3A4—liver—alcohol dependence	0.000346	0.0177	CbGeAlD
Linagliptin—CYP3A4—central nervous system—alcohol dependence	0.000346	0.0177	CbGeAlD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.00033	0.0177	CbGpPWpGaD
Linagliptin—ABCB1—digestive system—alcohol dependence	0.000328	0.0168	CbGeAlD
Linagliptin—ABCB1—blood—alcohol dependence	0.000313	0.016	CbGeAlD
Linagliptin—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000311	0.0167	CbGpPWpGaD
Linagliptin—ABCB1—midbrain—alcohol dependence	0.000309	0.0158	CbGeAlD
Linagliptin—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000299	0.016	CbGpPWpGaD
Linagliptin—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000297	0.0159	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000293	0.0157	CbGpPWpGaD
Linagliptin—ABCB1—endocrine gland—alcohol dependence	0.000271	0.0139	CbGeAlD
Linagliptin—ABCB1—testis—alcohol dependence	0.000259	0.0132	CbGeAlD
Linagliptin—ABCB1—nervous system—alcohol dependence	0.000254	0.013	CbGeAlD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000249	0.0134	CbGpPWpGaD
Linagliptin—ABCB1—liver—alcohol dependence	0.000245	0.0125	CbGeAlD
Linagliptin—ABCB1—central nervous system—alcohol dependence	0.000245	0.0125	CbGeAlD
Linagliptin—ABCB1—cerebellum—alcohol dependence	0.000239	0.0122	CbGeAlD
Linagliptin—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000235	0.0126	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000212	0.0114	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000203	0.0109	CbGpPWpGaD
Linagliptin—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000199	0.0107	CbGpPWpGaD
Linagliptin—ABCB1—brain—alcohol dependence	0.000194	0.00993	CbGeAlD
Linagliptin—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000188	0.0101	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000186	0.00996	CbGpPWpGaD
Linagliptin—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000159	0.00856	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000155	0.00834	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000154	0.00825	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000132	0.00709	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000131	0.00702	CbGpPWpGaD
Linagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000129	0.00692	CbGpPWpGaD
Linagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000127	0.00683	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000112	0.00603	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000108	0.00578	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000105	0.00561	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	9.86e-05	0.00529	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—POMC—alcohol dependence	9.62e-05	0.00516	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	8.6e-05	0.00461	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—MAOB—alcohol dependence	8.17e-05	0.00438	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	6.95e-05	0.00373	CbGpPWpGaD
Linagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	6.91e-05	0.00371	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—EP300—alcohol dependence	6.89e-05	0.0037	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	6.66e-05	0.00357	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	5.66e-05	0.00304	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	5.6e-05	0.003	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	5.55e-05	0.00298	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	5.48e-05	0.00294	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ADH6—alcohol dependence	5.21e-05	0.00279	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—GGT1—alcohol dependence	5.1e-05	0.00274	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—MAOA—alcohol dependence	4.57e-05	0.00245	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ADH1A—alcohol dependence	4.32e-05	0.00232	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ADH4—alcohol dependence	3.67e-05	0.00197	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ADH6—alcohol dependence	3.21e-05	0.00172	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	3.21e-05	0.00172	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ADH7—alcohol dependence	3.12e-05	0.00167	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GGT2—alcohol dependence	2.99e-05	0.00161	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—POMC—alcohol dependence	2.97e-05	0.0016	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	2.94e-05	0.00158	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ADH1B—alcohol dependence	2.74e-05	0.00147	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ADH1A—alcohol dependence	2.66e-05	0.00143	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	2.65e-05	0.00142	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—MAOB—alcohol dependence	2.27e-05	0.00122	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ADH4—alcohol dependence	2.26e-05	0.00121	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALDH2—alcohol dependence	1.93e-05	0.00103	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ADH7—alcohol dependence	1.92e-05	0.00103	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GGT2—alcohol dependence	1.84e-05	0.000989	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ADH1B—alcohol dependence	1.69e-05	0.000905	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GOT2—alcohol dependence	1.64e-05	0.00088	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP2E1—alcohol dependence	1.54e-05	0.000827	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GOT1—alcohol dependence	1.41e-05	0.000759	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GGT1—alcohol dependence	1.41e-05	0.000759	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—MAOB—alcohol dependence	1.4e-05	0.00075	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—MAOA—alcohol dependence	1.27e-05	0.00068	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALDH2—alcohol dependence	1.19e-05	0.000637	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GOT2—alcohol dependence	1.01e-05	0.000542	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP2E1—alcohol dependence	9.5e-06	0.000509	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GGT1—alcohol dependence	8.72e-06	0.000468	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GOT1—alcohol dependence	8.72e-06	0.000468	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—POMC—alcohol dependence	8.26e-06	0.000443	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—MAOA—alcohol dependence	7.81e-06	0.000419	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—EP300—alcohol dependence	5.48e-06	0.000294	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—POMC—alcohol dependence	5.09e-06	0.000273	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—EP300—alcohol dependence	3.37e-06	0.000181	CbGpPWpGaD
